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ABSTRACT 
Objective: Antibiotics are essential with inappropriate use leading to antimicrobial resistance (AMR). 
Currently, little is known about antibiotic use among hospitals in Kenya, which is essential to address 
as part of the recent national action plan to address rising AMR rates. Consequently, the objective 
was to address this gap in a leading referral hospital in Kenya. The findings will subsequently be used 
to develop quality improvement programmes for this and other hospitals in Kenya. Methods: A point 
prevalence survey. Data on antibiotic use was abstracted from patient medical records by a pharmacy 
team. Findings: Prevalence of antibiotic prescribing was 54.7%, highest in the ICU and isolation 
wards. Most antibiotics were for treatment (75.4%) rather than prophylaxis (29.0%). The majority of 
patients on surgical prophylaxis were on prolonged duration (>1 day), with only 9.6% on a single dose 
as per current guidelines. Penicillins (46.9%) followed by cephalosporins (44.7%) were the most 
prescribed antibiotic classes. The indication for antibiotic use was documented in only 37.3% of 
encounters. Generic prescribing was 62.5%, and empiric prescribing in 82.6% of encounters. 
Guideline compliance was 45.8%. Conclusion: Several areas for improvement were identified 
including assessing prolonged duration for prophylaxis, extensive prescribing of broad spectrum 
antibiotics, high prevalence of empiric prescribing and lack of documenting the indication. Initiatives 
are ongoing to address this with pharmacists playing a key role. 
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Introduction 
Antibiotics are widely prescribed globally with antibiotic use increasing by 36% during the past 
decade.[1] However, their overuse has increased rates of antimicrobial resistance (AMR), increasing 
morbidity, mortality and costs.[2] This has resulted in international and national  programmes to 
address rising AMR rates.[3,4] This is particularly important in countries such as Kenya with high rates 
of HIV and TB and growing AMR rates [5-7] , resulting in the recent launch of the Kenyan National 
Action Plan.[5] This includes a need for greater understanding of antibiotic use including hospitals to 
inform future policies.  
 
We have previously reported on concerns with antibiotic use in a referral hospital in Western Kenya 
and antibiotic prophylaxis to prevent surgical site infections (SSIs) in patients with neurotrauma.[8,9] 
However, we have not previously reported antibiotic utilisation patterns within a level 5 facility in 
Kenya. This is important as this is a leading teaching hospital in Kenya providing direction  to others. 
In addition, the recent Global Point Prevalence Survey (PPS) only contained data from five African 
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countries excluding Kenya and children.[10] Consequently, the study was undertaken to address this 
knowledge gap with Kenya one of the most populous African countries. The findings will be applicable 
across Kenya.  
 
METHODS 
A PPS study[8,10] was undertaken in April 2017 to ascertain the prevalence and patterns of antibiotic 
prescribing at a specific point in time at the Rift Valley Provincial General Hospital, a level 5 teaching 
hospital. It is the fourth largest government referral hospital in Kenya with  532 beds. 
 
All the neonatal, paediatric, adult and mixed departments were included. All patients who were 
receiving systemic antibiotic therapy at 8AM on the day of the survey were eligible, with the antibiotics 
including antibacterials for systemic use (J01), tuberculosis (J04A), intestinal anti-infectives (A07AA) 
and anti-protozoals (P01AB).[11] Outpatients and daytime admissions for ambulatory patients for 
procedures such as endoscopy or renal dialysis were excluded as well as antibiotics for topical use.  
 
Antibiotic use was recorded by prescription, with usage broken down into either prophylaxis or 
treatment. Prophylaxis was further divided into medical or surgical prophylaxis. Medical prophylaxis 
was documented when antibiotics were prescribed to prevent infections in patients with medical 
conditions. Surgical prophylaxis included the use of antibiotics to prevent SSIs.[9] The extent of co-
morbidities were also recorded including HIV, which is particularly prevalent in sub-Sarah Africa for 
patients admitted to hospitals.[12] Infections were further divided into community acquired infection 
(CAI) and hospital acquired infections (HAI), especially given the extent of HAIs in sub-Sahara 
Africa.[13] 
 
CAIs were documented if symptoms started <48 hours from admission to hospital (or present on 
admission), and HAIs if symptoms started 48 hours after admission.[10,13] We also assessed whether 
there was an association between antibiotic classes and departments for possible future 
interventions. 
 
Prescribing patterns were assessed against the findings of the Global PPS study especially among 
African countries.[10] The quality of antibiotic prescribing was also assessed by evaluating whether the 
reason for the prescription was documented, current generic prescribing rates and the extent of 
empiric versus targeted prescribing. Guideline compliance was also assessed. Whilst there is 
currently no hospital formulary, prescriptions are guided by the Kenyan Essential Medicine List and 
relevant international guidelines.[14,15] This formed the basis of whether treatment was guideline 
compliant or not. Sampling of patients¶QRWHV was undertaken as part of ethical approval. The sample 
size was calculated using the Fischer formula adjusted for average hospital bed occupancy.[16] 
However, there was no sampling for antibiotic use. 
 
On the day of the survey, the total number of patients admitted by 8AM was recorded followed by the 
total number of patients on systemic antibiotics at 8AM. The medical records of all inpatients on 
systemic antibiotics were obtained, with their file numbers entered onto Microsoft Excel, with the 
computer providing a random sample of files to be studied in full. There was  no direct engagement of 
patients. The patient files were subsequently reviewed by the data collectors including medical 
students led by a pharmacist, and the data entered onto the PPS form. Data was recorded as 
anonymous by employing a study number for each patient. The data was subsequently validated for 
completeness and correctness by two other pharmacists. 
 
To calculate the prevalence of antibiotic use, the denominator was the total number of admitted 
patients while the numerator was the total number of patients on systemic antibiotics at 8AM of the 
day the ward was surveyed.  
 
The prevalence of antibiotic use in the various departments including whether for prophylaxis or 
treatment was also calculated. Descriptive statistics were used to summarise and describe the study 
variables as appropriate by using means and standard deviations for continuous variables while using 
frequency and percentages for categorical variables.  The Chi-square test was used to test the 
association between the use of various antibiotic classes among the different hospital departmnets, 
where as the Fisher exact test was used instead of the Chi-square test when the Chi-square test 
DVVXPSWLRQVRIWKHH[SHFWHGYDOXHVLQYDULXRUVFHOOVZHUHRUQRH[SHFWHGYDOXHVZHUH
were violated; consequently, invalid. 
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Ethical approval was obtained from the KNH-UON Ethics committee reference number P36/01/2017. 
Further approval was obtained from the hospital administration of the RVPGH before commencement 
of the study. Confidentiality of the data was highly regarded.  
 
RESULTS 
The study was conducted on 179 patients whose median age was 25.3 years (IQR = 4 - 38). Adults 
(20-59 years) formed the largest proportion (93, 52%) followed by neonates (23, 12.9%). There were 
more females (99, 55.3%) than males (44.6%). The adult surgical ward (53, 29.6%) and the adult 
medical ward (41, 22.9%) had the largest proportion of patients with least in the intensive care unit 
(ICU) (4, 2.2%). 
 
The overall prevalence of antibiotic prescribing was 54.7%, with the highest  level of prescribing  for 
treatment (75.4%).  
 
The ICU (100.0%) and the isolation ward (100.0%), classified under a mixed department, had the 
highest prevalence of antibiotic prescribing (100.0%), followed by the new born unit (93.7%), the 
paediatric medical ward (84.2%), the adult medical ward (61.5%) and the adult surgical ward (57.3%). 
The OBGYN department had the least prevalence of antibiotic prescribing (20.8%).  
 
The majority of patients had no comorbidities (96, 53.6%). Among those with comorbidities, the most 
prevalent was HIV (8.4%) followed by diabetes mellitus (6.7%), low birth weight (6.7%), anaemia 
(5.6%), respiratory distress (5.0%) and hypertension (3.9%). The most frequent indication for 
antibiotic use was for CAIs (54.2%) followed by prolonged surgical prophylaxis at > 1 day (22.4%), 
medical prophylaxis (15.1%),1 day surgical prophylaxis (3.9%), single dose surgical prophylaxis 
(2.8%) and HAIs (2.8%). 
 
The respiratory system was the anatomical site with the greatest proportion of antibiotics prescribed 
for treatment (24.6%) followed by the skin, soft tissue, bone and joint infections (SSTBJ) at 12.3%. 
Eyes (0.6%), the cardiovascular system (0.6%) and ENT (0%) had the least antibiotics prescribed. For 
prophylactic use, obstetric or gynecological (OBGYN) surgery was highest (10.1%) followed by 
SSTBJ anatomical sites (8.9%), with the least for urinary tract infections (0%) and the cardiovascular 
system (0%). 
 
 
The penicillins (46.9%) (J01C) were the most prescribed class followed by the cephalosporins 
(44.7%) (J01D) and aminoglycosides (26.3%) (J01G). There was limited prescribing of the 
furadantoins (0.6%) (J01XE) (Figure 1).  
 
Individually, ceftriaxone was the most prescribed antibiotic (39.7%) followed by benzyl penicillin 
(29.0%) and metronidazole (25.1%) (Table 1). 
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Table 1: Prevalence of specific antibiotics prescribed  
 
 Specific antibiotics N % 
Cephalosporins Ceftriaxone 71 39.7 
 Ceftazidime   7   3.9 
Penicillins Benzyl penicillin 52 29.0 
Flucloxacillin 20 11.2 
Ampicillin/cloxacillin 14   7.8 
Amoxicillin/ 
clavulanic acid 10   5.6 
Amoxicillin   4   2.2 
Nitroimidazole derivatives Metronidazole 45 25.1 
Aminoglycosides Gentamicin 40 22.3 
Amikacin   7   3.9 
Rifamycins Rifampicin 11   6.1 
Macrolides Erythromycin 10   5.6 
 Clarithromycin   1   0.6 
Lincosamides Clindamycin   7   3.9 
Sulfonamides Cotrimoxazole   5   2.8 
Chloramphenicol Chloramphenicol   3   1.7 
Quinolones Ciprofloxacin   3   1.7 
Levofloxacin   1   0.6 
Tetracyclines Doxycycline   2   1.1 
Carbapenems Meropenem   2   1.1 
Glycopeptides Vancomycin   2   1.1 
Furadantoins Nitrofurantoin   1   0.6 
Others Ethambutol 12   6.7 
Pyrazinamide 12   6.7 
Isoniazid 11   6.1 
Capreomycin   2   1.1 
Cycloserine   1   0.6 
Prothionamide   1   0.6 
 
There was a statistically significant association between antibiotic prescribing and departments. 
Aminoglycosides were commonly prescribed in the paediatric medical wards (p<0.001). Macrolides 
(p=0.002), nitroimidazole derivatives (p=0.002) and anti-tuberculosis antimicrobials (p<0.001) were 
the most frequently prescribed in the adult medical wards. Penicillins (p=0.002) were commonly 
prescribed in the adult surgical wards. Tetracyclines were prescribed mostly in the OBGYN 
departments (P=0.004). Carbapenems were commonly prescribed in the ICU and paediatric medical 
wards (p=0.002) (Table 2). 
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Table 2: Variation of antibiotic prescribing by classes across the various departments 
 
 
  PMW NMW AMW ASW 
 
 
ICU OBGY MIXED P Value 
Antibiotic Class n (%) n (%) n (%) n (%) 
 
n (%) n (%) n (%)  
Aminoglycosides 17 (9.5) 13 (7.3) 6 (3.3) 8 (4.5) 
 
2 (1.1) 1 (0.6) 0 (0.0) <0.001 
Cephalosporins 16 (8.9) 2 (1.1)   19(10.6) 29 (16.2) 
 
2 (1.1) 7 (3.9) 5 (2.8) 0.114 
Penicillins 16 (8.9) 13 (7.3) 13 (7.3) 27 (15.1) 
 
0 (0.0) 5 (2.79) 10 (5.6) 0.002 
Macrolides 0 (0.0) 0 (0.0) 4 (2.2) 0 (0.0) 
 
0 (0.0) 3 (1.7) 4 (2.2) 0.002 
Quinolones 0 (0.0) 0 (0.0) 2 (1.1) 2 (1.1) 
 
0 (0.0) 0 (0.0) 1 (0.6) 0.758 
Nitroimidazole  2 (1.1) 1 (0.6) 10 (5.6) 2 (1.1) 
 
0 (0.0) 7 (3.9) 2 (1.1) 0.002 
Carbapenems  1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 
 
1 (0.6) 0 (0.0) 0 (0.0) 0.002 
Sulfonamides 1(0.6) 0 (0.0) 3 (1.7) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0 (0.0) 0.287 
Glycopeptides 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 
 
0 (0.0) 0 (0.0) 1 (0.6) 0.409 
Chloramphenicol 0 (0.0) 0 (0.0) 1 (0.6) 0 (0.0) 
 
0 (0.0) 0 (0.0) 1 (0.6) 0.480 
Lincosamide 1 (0.6) 0 (0.0) 0 (0.0) 6 (3.3) 
 
0 (0.0) 0 (0.0) 0 (0.0) 0.071 
Tetracycline 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 
0 (0.0) 2 (1.1) 0 (0.0) 0.004 
Furadantoins 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 
1 (0.6) 0 (0.0) 0 (0.0) <0.001 
Rifamycins 2 (1.1) 0 (0.0) 9 (5.0) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0 (0.0) <0.001 
Isoniazid 2 (1.1) 0 (0.0) 9 (5.0) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0 (0.0) <0.001 
Pyrazinamide 2 (1.1) 0 (0.0) 10 (5.6) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0 (0.0) <0.001 
Ethambutol 2 (1.1) 0(0.0) 9 (5.0) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0(0.0) <0.001 
Others 0 (0.0) 0(0.0) 1 (0.6) 0 (0.0) 
 
0 (0.0) 0 (0.0) 0 (0.0) 0.759 
Key: PMW ± Paediatric Medical Ward; NMW ± Neonatal Medical Ward; AMW ± Adult Medical Ward 
ASW ± Adult Surgical Ward; OBGYN ± Obstetrics & Gynecology; ICU ± Intensive Care Unit; Mixed ± all those 
departments that have both adults and paediatrics in the same ward 
 
The pattern of antibiotic prescribing varied by indication (Figure 2). 
 
The most commonly prescribed antibiotic classes for respiratory infections were aminoglycosides 
(19.5%) and penicillins (18.6%). For SSTBJ infections, cephalosporins (37.8%) and penicillins 
(27.0%) were commonly prescribed. For neonatal infections, aminoglycosides (41.2%) and penicillins 
(41.2%) were commonly prescribed. 
 
Less than half of the patients were on a single antibiotic (41.3%), with the majority (58.7%) on 
combination therapy, and 17.9% having 3 or more antibiotics. The most prevalent antibiotic 
combinations were aminoglycosides and penicillins (20.7%) followed by cephalosporins and 
nitroimidazole derivatives (13.4%), penicillins and nitroimidazole derivatives (9.5%) and 
cephalosporins and penicillins (6.7%). There were also some unusual combinations.  
 
The reason for the antibiotic prescription was documented in 37.3% (n=133) of occasions. 
Clarithromycin, levofloxacin and the anti-tuberculosis antimicrobials had the reason for their use 
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documented all the time. Ampicillin cloxacillin, doxycycline, nitrofurantoin and vancomycin did not 
have their reason documented at all. The generic prescribing rate was 62.5%, whilst the empiric 
prescribing rate was 82.6%. Four antimicrobials which were always used for targeted therapy 
including clarithromycin, cycloserine, prothionamide and levofloxacin. Overall, antimicrobial 
prescribing was guideline compliant on 45.8% of occasions.  
 
DISCUSSION 
The prevalence of antibiotic prescribing was 54.7%, comparable to Nigerian hospitals at 55.9%[17], 
Egyptian hospitals at 59%,[18], Western Kenya at 67.7%,[8] Uganda (79%),[19] and Ghana (51.4%),[20]  
as well as the African countries in the Global PPS (50.0%).[10] However, higher than the overall rate in 
the Global PPS study (34.1%).[10]  This may reflect the higher burden of infectious diseases among 
African countries including Kenya.[6,7,12]  
 
The ICU and the isolation departments had the highest rate of antibiotic prescribing (100%), similar to 
Egypt, [18] and the African countries in the Global PPS,[10] probably due to the critical nature of the 
SDWLHQWV¶LOOQHVVDQGLQFUHDVHGULVNRILQIHFWLRQV especially if patients are on a ventilator.[21] The 
OBGYN department (20.8%) had the least prevalence of antibiotic prescribing, similar to Ghana[20] but 
different to a previous Kenyan study.[8]. 
 
75.4% of antibiotic prescribing was for treatment, similar to the Global PPS.[10] The respiratory system 
had the largest proportion of antibiotics prescribed (24.6%) followed by SSTBJ infections (12.3%), 
similar to Egypt,[18] and a previous study in Kenya.[8] The gynaecological system had the highest 
proportion of prophylactic antibiotic use (10.1%) again similar to Egypt [18] and a previous Kenyan 
study.[8] This could be due to the frequent use of prophylactic antibiotics for caesarean sections. 
 
The most common indication for antibiotic use was CAIs (54.2%) followed by surgical prophylaxis 
(29.1%) similar to African countries in the Global PPS (57.4%, 23.2%), and Ghana (40.1%, 33.6%) 
respectively.[10, 20] HAIs accounted for 2.8% of antibiotic prescribing, comparable to Egypt [18] but 
considerably lower than the African countries in the Global PPS (9.5%) and generally across Africa, 
[10,13, 20]  which maybe due to poor documentation in our study. 
 
The use of penicillins was prevalent across indications (Table 2, Figure 2). Cephalosporins were the 
most prescribed class for CAIs (24.1%) with ceftriaxone the most prescribed (91.3%). Ceftriaxone was 
also the most prescribed agent for single dose surgical prophylaxis (100%), similar to a previous 
Kenyan study for patients with neurotrauma,[9]  African countries in the Global PPS and other African 
countries [10,19,22,23]  This is a concern as ceftriaxone is a broad spectrum antibiotic used first-line in 
many bacterial infections, and over use will increase AMR rates, with guidelines advocating against 
broad spectrum antibiotics in this situation.[24]   In addition, the majority (76.9%) of patients on surgical 
prophylaxis were on prolonged duration (>1 day) with only 9.6% on a single dose as per current 
guidelines,[24] similar to Egypt[18] and Botswana.[22] This prolonged use may be due to misconceptions 
that this reduces SSIs,[17,22] and a key area for improvement. In Thika hospital in Kenya, another level 
5 hospital, there was a 98% adherence to the policy to improve surgical prophylaxis within six weeks 
of implementation of a program, leading to a significant reduction in the risk of SSIs,[25] providing 
guidance to other hospitals. 
 
Other concerns include clinically unjustified antibiotic combinations, the reason for which 
antimicrobials were prescribed was recorded in only 37.3% of all encounters, and only 45.8% of 
prescriptions were guideline compliant . In addition,  empiric prescribing accounted for 82.6% of total 
antibiotic encounters. This needs addressing. Another concern is that generic (INN) prescribing was 
documented in only 62.5% of cses, although an improvement compared to 31.8% in 2008.[26]  
Antimicrobial stewardship (AMS) programmes can help with quality improvement programmes, with 
pharmacists playing a key role in their implementation and the monitoring of subsequent antibiotic 
use.[27] 
 
The study had several limitations. There were challenges in obtaining all relevant medical records and 
limitations with the PPS study design including not documenting AMR rates and not contacting 
physicians to clarify their actions. Notwithstanding this, we identified several potential areas for 
improvement.  
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In conclusion, the prevalence of antibiotic prescribing at RVPGH was high although similar to other 
African countries. There was also extensive use of broad spectrum antibiotics and prolonged duration 
of antibiotic prophylaxis, which is being addressed along with increasing documentation of antibiotic 
indications in patient charts and reducing empiric use of antibiotics. Other interventions to improve 
futute antibiotic use include establishing AMS programmes with the help of pharmacists.  
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Figure 1: Prevalence of antibiotic prescribing by class 
 
 
Figure 2: Antibiotic prescribing by indication 
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